TrialThe journal of headache and pain2018

Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study.

Stephen Landy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.